Leonabio Inc (LONA)

Jan 13, 2026

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker "LONA" - Investing News Network

Jan 13, 2026

Jan 12, 2026

Athira Pharma (ATHA) Options to Be Delisted on January 12th - GuruFocus

Jan 12, 2026

Jan 09, 2026

Athira Pharma Rebrands as LeonaBio, Refocusing on Oncology - TipRanks

Jan 09, 2026

Jan 09, 2026

Athira Pharma announces name change to LeonaBio - TipRanks

Jan 09, 2026

Jan 09, 2026

Athira Pharma roars into the new year with rebrand to LeonaBio - Fierce Pharma

Jan 09, 2026

Jan 09, 2026

Athira Pharma changes name, ticker symbol - MSN

Jan 09, 2026

Jan 09, 2026

Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy - Investing.com Nigeria

Jan 09, 2026

Jan 09, 2026

Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy By Investing.com - Investing.com South Africa

Jan 09, 2026

Jan 09, 2026

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA” - Yahoo Finance

Jan 09, 2026

Dec 18, 2025

New breast cancer drug moves into late testing with $236M funding deal - Stock Titan

Dec 18, 2025

Sep 11, 2025

Athira Pharma Announces Reverse Stock Split - GlobeNewswire

Sep 11, 2025

Sep 17, 2024

Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases - marketscreener.com

Sep 17, 2024

Aug 01, 2024

Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer's Disease-Related Pathology - marketscreener.com

Aug 01, 2024

Nov 28, 2023

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND - marketscreener.com

Nov 28, 2023

May 11, 2023

Athira Pharma, Inc. Plans to Further Extend the Current OLEX for the Phase 2/3 LIFT-AD and Phase 2 ACT-AD Trials - marketscreener.com

May 11, 2023

Jan 05, 2023

Athira Pharma Provides 2023 Pipeline Outlook - marketscreener.com

Jan 05, 2023

May 12, 2022

Athira Pharma Reports First Quarter 2022 Financial Results and Provides Pipeline and Business Updates - marketscreener.com

May 12, 2022

Oct 27, 2021

Alzheimer’s Disease Stock Cortexyme Craters on Trial Failure - Bloomberg.com

Oct 27, 2021

Sep 17, 2020

ATHAAthira Pharma, Inc. Latest Stock News & Market Updates - Stock Titan

Sep 17, 2020